Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03113786 · ClinicalTrials.gov registry record · Phase 4
CLARIX™ 100 & CLARIX CORD 1K for Discectomy Patients
A Phase 4 study, sponsored by Amniox Medical.
- Completed
- Registry status
- Phase 4
- Development phase
- 32
- Enrollment target
NCT03113786 is a Phase 4 study that has completed, run by Amniox Medical. The registered enrollment target is 32 participants.
The verdict
NCT03113786, a Phase 4 study, has completed, sponsored by Amniox Medical.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 32 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate the efficacy of CLARIX™ 100 and CLARIX™ CORD 1K as a tissue barrier when used as an annular patch in discectomy patients with low back \& leg pain when compared to traditional discectomy patient outcomes. This will be a 120 patient, prospective randomized study model over a 5 year post-operative period.
Interventions
- OTHER CLARIX™100
- OTHER CLARIX CORD 1K
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2011-11-02 |
| Est. Completion | 2020-04-21 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03113786
The ClinicalTrials.gov registry entry for NCT03113786 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Amniox Medical, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which CLARIX™100 is the first listed.
NCT03113786 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03113786 about?
NCT03113786 is a clinical study titled "CLARIX™ 100 & CLARIX CORD 1K for Discectomy Patients". The purpose of the study is to evaluate the efficacy of CLARIX™ 100 and CLARIX™ CORD 1K as a tissue barrier when used as an annular patch in discectomy patients with low back \& leg pain when compared to traditional discectomy patient outcomes. This will be a 120 patient, prospective randomized stud...
What is the current status of trial NCT03113786?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 32 participants. The study started on 2011-11-02. Estimated completion is 2020-04-21.
What interventions are being tested in trial NCT03113786?
The interventions under investigation include: CLARIX™100 (OTHER), CLARIX CORD 1K (OTHER).
Who is sponsoring clinical trial NCT03113786?
This trial is sponsored by Amniox Medical, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.